Cedric Constant
CEO
Cerhum
2025
14:00
Innovation Stage
Lab to Life – Industry meets Application
2024
Cedric Constant
Cedric is the CEO of Cerhum, an innovative Belgian medtech company producing patient-specific, 3D-printed bioceramic bone grafts, initially targeting maxillofacial and pre-implantation surgeries. Cerhum developed a new generation of implant porosity that significantly enhances osteoconductivity, offering a compelling alternative to autografts and allografts in orthognathic surgery and complex reconstructions. In facial contouring indications, it offers a patient-specific implant (PSI) with a bone-like composition that optimally supports the body’s natural healing process, as a superior alternative to polymer-based (e.g., PEEK) and titanium PSIs.